Carregant...
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3′deoxy-3′fluoro-l-thymidine positron emission tomography/computed tomography
PURPOSE: Rapid disease progression associated with increased tumor proliferation has been observed during withdrawal of anti-angiogenic therapy. We characterize the dynamics of withdrawal flare for axitinib. METHODS: Thirty patients with metastatic solid malignancies received axitinib for 2 weeks, f...
Guardat en:
| Publicat a: | Cancer Chemother Pharmacol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4499265/ https://ncbi.nlm.nih.gov/pubmed/26021741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-015-2779-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|